Status:
COMPLETED
Study on the Prevalence of Human Papillomavirus Types in Women >= 15 Years of Age in the Kingdom of Saudi Arabia
Lead Sponsor:
GlaxoSmithKline
Conditions:
Infections, Papillomavirus
Cervical Cancer
Eligibility:
FEMALE
15+ years
Brief Summary
This study aims to determine the prevalence of human papillomavirus (HPV) and to assess the HPV type distribution among women \>= 15 years of age, attending routine gynaecological examination in the K...
Eligibility Criteria
Inclusion
- Subjects/Subjects' parents or guardians, who the investigator believes that they can and will comply with the requirements of the protocol should be enrolled in the study,
- Women \>=15 years of age attending a clinic for routine cervical screening,
- Written informed consent obtained from the subject and/or subject's parent/guardian.
Exclusion
- Referral for abnormal cervical sample at the current visit,
- Abundant menstrual bleeding or vaginal discharge not allowing appropriate screening to be performed,
- No cervical sample provided,
- History of hysterectomy,
- Known diagnosis of immunosuppression, or patient on immunosuppressives,
- Pregnant female \>=25 years of age.
Key Trial Info
Start Date :
April 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2011
Estimated Enrollment :
420 Patients enrolled
Trial Details
Trial ID
NCT01213459
Start Date
April 1 2010
End Date
December 1 2011
Last Update
November 22 2012
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
GSK Investigational Site
Riyadh, Saudi Arabia, 11211
2
GSK Investigational Site
Riyadh, Saudi Arabia